Seung-Taek Sun

Title: Seung-Taek Sun: Innovator in Epidermal Growth Factor Mutants

Introduction

Seung-Taek Sun is a prominent inventor based in Seoul, South Korea. He is known for his significant contributions to the field of biotechnology, particularly in the development of epidermal growth factor (EGF) mutants. His innovative work has the potential to revolutionize cosmetic applications and skin regeneration therapies.

Latest Patents

Seung-Taek Sun holds a patent for "Highly stabilized epidermal growth factor mutants." This patent describes mutants created by altering a DNA base sequence and an amino acid sequence of EGF. The resulting mutant EGF protein exhibits excellent thermal stability and remains stable in aqueous solutions. The patent also includes a gene encoding the protein, a recombinant vector containing the gene, and a microorganism transformed by this vector. Furthermore, it outlines a method for preparing the mutant EGF protein and a cosmetic composition designed to accelerate skin cell growth and regeneration. This innovation allows for the production of functional cosmetics that maintain their activity during distribution and storage, unlike conventional wild-type EGF products.

Career Highlights

Seung-Taek Sun is associated with PNP Biopharm Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in the cosmetic industry, particularly in enhancing skin health and regeneration.

Collaborations

Seung-Taek Sun collaborates with notable colleagues, including Hang-Cheol Shin and Dong-hwan Kim. Their combined expertise contributes to the innovative projects at PNP Biopharm Co., Ltd.

Conclusion

Seung-Taek Sun's contributions to the field of biotechnology, particularly through his patent on stabilized EGF mutants, highlight his role as a key innovator in cosmetic science. His work promises to enhance the effectiveness of skincare products and improve skin regeneration processes.